MedWatch

Ferrosan's financials could have motivated Lundbeck and partners' new investment

Kirk Kapital, ATP and the Lundbeck Foundation have invested in a very profitable and growing company – but it was hardly a steal.

Kirk Kapital's Danish offices | Photo: Jens Dresling

The Danish company being bought by the Lundbeck Foundation, LEGO family office Kirk Kapital, and Danish pension fund ATP is a well-functioning and operational company.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs